1. Lu, Chenglu, Chen, Shuai, Liu, Shasha, Sun, Lin, Sun, Yan. 2024. Determination of the Immunomodulatory Role of OTOP2 in Colon Adenocarcinoma. In Journal of Cancer, 15, 4838-4852. doi:10.7150/jca.95622. https://pubmed.ncbi.nlm.nih.gov/39132149/
2. Guo, Shuai, Sun, Yang. 2022. OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, Proliferation and Epithelial-Mesenchymal Transition: Evidence from Bioinformatics Data Mining and Experimental Verification. In Cancer management and research, 14, 1371-1384. doi:10.2147/CMAR.S345299. https://pubmed.ncbi.nlm.nih.gov/35418782/
3. Malonga, Tania, Vialaneix, Nathalie, Beaumont, Martin. 2024. BEST4+ cells in the intestinal epithelium. In American journal of physiology. Cell physiology, 326, C1345-C1352. doi:10.1152/ajpcell.00042.2024. https://pubmed.ncbi.nlm.nih.gov/38557358/
4. Qu, Huajun, Su, Yi, Yu, Lianzhi, Zhao, Hongchao, Xin, Chunxia. 2018. Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the promoter in colorectal cancer. In FEBS open bio, 9, 26-34. doi:10.1002/2211-5463.12554. https://pubmed.ncbi.nlm.nih.gov/30652071/
5. Sallinger, Katja, Gruber, Michael, Müller, Christin-Therese, Kroneis, Thomas, El-Heliebi, Amin. 2023. Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse. In Journal of translational medicine, 21, 528. doi:10.1186/s12967-023-04384-0. https://pubmed.ncbi.nlm.nih.gov/37543577/
智鼠故事 
